Review of the molecular profile and modern prognostic markers for gastric lymphoma: How do they affect clinical practice?

被引:12
作者
Alevizos, Leonidas [1 ]
Gomatos, Ilias P. [1 ]
Smparounis, Spyridon [1 ]
Konstadoulakis, Manousos M. [1 ]
Zografos, Georgios [1 ]
机构
[1] Hippokrateion Hosp, Athens Med Sch, Dept Propaedeut Surg 1, Athens 11527, Greece
关键词
NON-HODGKINS-LYMPHOMA; B-CELL LYMPHOMA; QUANTITATIVE IMMUNOCYTOCHEMICAL ASSAYS; GASTROINTESTINAL STROMAL TUMOR; LOW-GRADE; HELICOBACTER-PYLORI; MALT-LYMPHOMA; MICROSATELLITE INSTABILITY; ADHESION MOLECULES; PROTEIN EXPRESSION;
D O I
10.1503/cjs.002310
中图分类号
R61 [外科手术学];
学科分类号
摘要
Primary gastric lymphoma is a rare cancer of the stomach with an indeterminate prognosis. Recently, a series of molecular prognostic markers has been introduced to better describe this clinical entity. This review describes the clinical importance of several oncogenes, apoptotic genes and chromosomal mutations in the initiation and progress of primary non-Hodgkin gastric lymphoma and their effect on patient survival. We also outline the prognostic clinical importance of certain cellular adhesion molecules, such as ICAM and PECAM-1, in patients with gastric lymphoma, and we analyze the correlation of these molecules with apoptosis, angiogenesis, tumour growth and metastatic potential. We also focus on the host-immune response and the impact of Helicobacter pylori infection on gastric lymphoma development and progression. Finally, we explore the therapeutic methods currently available for gastric lymphoma, comparing the traditional invasive approach with more recent conservative options, and we stress the importance of the application of novel molecular markers in clinical practice.
引用
收藏
页码:117 / 124
页数:8
相关论文
共 90 条
  • [1] Indomethacin-induced apoptosis in esophageal adenocarcinoma cells involves upregulation of Bax and translocation of mitochondrial cytochrome c independent of COX-2 expression
    Aggarwal, S
    Taneja, N
    Lin, L
    Orringer, MB
    Rehemtulla, A
    Beer, DG
    [J]. NEOPLASIA, 2000, 2 (04): : 346 - 356
  • [2] Molecular Biomarkers Correlate with Disease-Free Survival in Patients with Anal Canal Carcinoma Treated with Chemoradiation
    Ajani, Jaffer A.
    Wang, Xuemei
    Izzo, Julie G.
    Crane, Christopher H.
    Eng, Cathy
    Skibber, John M.
    Das, Prajnan
    Rashid, Asif
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (04) : 1098 - 1105
  • [3] Loss of HLA molecules in B lymphomas is associated with an aggressive clinical course
    Amiot, L
    Onno, M
    Lamy, T
    Dauriac, C
    Le Prise, PY
    Fauchet, R
    Drenou, B
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1998, 100 (04) : 655 - 663
  • [4] Management and long-term follow-up of early stage H. pylori-associated gastric MALT-lymphoma in clinical practice: An Italian, multicentre study
    Andriani, A.
    Miedico, A.
    Tedeschi, L.
    Patti, C.
    Di Raimondo, F.
    Leone, M.
    Schinocca, L.
    Romanelli, A.
    Bonanno, G.
    Linea, C.
    Giustini, M.
    Hassan, C.
    Cottone, M.
    Zullo, A.
    [J]. DIGESTIVE AND LIVER DISEASE, 2009, 41 (07) : 467 - 473
  • [5] CD4+T-cell immune response to large B-cell non-Hodgkin's lymphoma predicts patient outcome
    Ansell, SM
    Stenson, M
    Habermann, TM
    Jelinek, DF
    Witzig, TE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (03) : 720 - 726
  • [6] Aydin ZD, 2000, CANCER-AM CANCER SOC, V89, P12, DOI 10.1002/1097-0142(20000701)89:1<12::AID-CNCR3>3.0.CO
  • [7] 2-Y
  • [8] AZAB MB, 1989, CANCER-AM CANCER SOC, V64, P1208, DOI 10.1002/1097-0142(19890915)64:6<1208::AID-CNCR2820640608>3.0.CO
  • [9] 2-Z
  • [10] BAILEY RL, 1989, AM SURGEON, V55, P665